NASDAQ: VRAY | Healthcare / Medical Devices & Instruments / USA |
4.69 | -0.0700 | -1.47% | Vol 607.70K | 1Y Perf 16.38% |
Feb 3rd, 2023 16:00 DELAYED |
BID | 4.65 | ASK | 4.73 | ||
Open | 4.69 | Previous Close | 4.76 | ||
Pre-Market | - | After-Market | 4.65 | ||
- - | -0.04 -0.85% |
Target Price | 7.14 | Analyst Rating | Strong Buy 1.29 | |
Potential % | 52.24 | Finscreener Ranking | ★★+ 47.37 | |
Insiders Trans % 3/6/12 mo. | 100/100/100 | Value Ranking | ★+ 43.03 | |
Insiders Value % 3/6/12 mo. | 100/100/100 | Growth Ranking | ★ 38.31 | |
Insiders Shares Cnt. % 3/6/12 mo. | 100/100/100 | Income Ranking | — - | |
Price Range Ratio 52W % | 89.49 | Earnings Rating | Strong Sell | |
Market Cap | 850.84M | Earnings Date | 27th Feb 2023 | |
Alpha | -0.00 | Standard Deviation | 0.21 | |
Beta | 1.10 |
Today's Price Range 4.644.78 | 52W Range 2.394.96 | 5 Year PE Ratio Range -5.10-4.40 |
Summary:
Buy
Technical Indicators: | Buy |
Moving Averages: | Strong Buy |
Performance | |||
---|---|---|---|
1 Week | 3.76% | ||
1 Month | 9.84% | ||
3 Months | 6.11% | ||
6 Months | 42.12% | ||
1 Year | 16.38% | ||
3 Years | 50.32% | ||
5 Years | -45.78% | ||
10 Years | - |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | -58.39 | |||
ROE last 12 Months | -104.49 | |||
ROA (5Y Avg) | -22.71 | |||
ROA last 12 Months | -44.36 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | -57.81 | |||
Return on invested Capital Q | -13.80 | |||
Return on invested Capital Y | -12.28 | |||
Assets Turnover | 0.30 | |||
Receivables Turnover | 2.90 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
-8.10 | ||||
8.28 | ||||
12.39 | ||||
- | ||||
-11.90 | ||||
-0.42 | ||||
8.28 | ||||
0.57 | ||||
788.62M | ||||
Forward PE | -8.07 | |||
PEG | - |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
2.10 | ||||
2.70 | ||||
0.38 | ||||
0.65 | ||||
-26.90 | ||||
Leverage Ratio | 2.20 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
6.20 | ||||
-116.90 | ||||
-111.10 | ||||
-153.10 | ||||
- |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
67.52M | ||||
0.37 | ||||
-4.81 | ||||
22.61 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
- | ||||
- | ||||
Payout ratio | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q03 2022 | -0.14 | -0.14 | 0.00 |
Q02 2022 | -0.15 | -0.15 | 0.00 |
Q01 2022 | -0.16 | -0.14 | 12.50 |
Q04 2021 | -0.15 | -0.16 | -6.67 |
Q03 2021 | -0.16 | -0.15 | 6.25 |
Q02 2021 | -0.16 | -0.19 | -18.75 |
Q01 2021 | -0.16 | -0.17 | -6.25 |
Q04 2020 | -0.17 | -0.18 | -5.88 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
12/2022 QR | -0.15 | -15.38 | Negative |
12/2022 FY | -0.59 | -3.51 | Negative |
3/2023 QR | -0.14 | 0.00 | - |
12/2023 FY | -0.56 | -12.00 | Negative |
Next Report Date | 27th Feb 2023 |
Estimated EPS Next Report | -0.16 |
Estimates Count | 6 |
EPS Growth Next 5 Years % | - |
Volume Overview | |
---|---|
Volume | 607.70K |
Shares Outstanding | 181.42K |
Shares Float | 153.45M |
Trades Count | 5.34K |
Dollar Volume | 2.86M |
Avg. Volume | 946.43K |
Avg. Weekly Volume | 976.23K |
Avg. Monthly Volume | 1.08M |
Avg. Quarterly Volume | 778.18K |
ViewRay Inc. (NASDAQ: VRAY) stock closed at 4.69 per share at the end of the most recent trading day (a -1.47% change compared to the prior day closing price) with a volume of 607.70K shares and market capitalization of 850.84M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 309 people. ViewRay Inc. CEO is Scott W. Drake.
The one-year performance of ViewRay Inc. stock is 16.38%, while year-to-date (YTD) performance is 4.69%. VRAY stock has a five-year performance of -45.78%. Its 52-week range is between 2.39 and 4.96, which gives VRAY stock a 52-week price range ratio of 89.49%
ViewRay Inc. currently has a PE ratio of -8.10, a price-to-book (PB) ratio of 8.28, a price-to-sale (PS) ratio of 12.39, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -44.36%, a ROC of -57.81% and a ROE of -104.49%. The company’s profit margin is -%, its EBITDA margin is -111.10%, and its revenue ttm is $67.52 Million , which makes it $0.37 revenue per share.
Of the last four earnings reports from ViewRay Inc., there were 1 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.16 for the next earnings report. ViewRay Inc.’s next earnings report date is 27th Feb 2023.
The consensus rating of Wall Street analysts for ViewRay Inc. is Strong Buy (1.29), with a target price of $7.14, which is +52.24% compared to the current price. The earnings rating for ViewRay Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
ViewRay Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
ViewRay Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 11.71, ATR14 : 0.20, CCI20 : 49.86, Chaikin Money Flow : 0.16, MACD : 0.03, Money Flow Index : 55.47, ROC : 0.64, RSI : 53.79, STOCH (14,3) : 59.00, STOCH RSI : 0.77, UO : 50.31, Williams %R : -41.00), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of ViewRay Inc. in the last 12-months were: B. Kristine Johnson (Buy at a value of $112 704), Brian K. Roberts (Buy at a value of $47 680), Caley Castelein (Buy at a value of $3 601 119), Daniel Jeffrey Moore (Buy at a value of $250 001), Karen N. Prange (Buy at a value of $100 002), Scott W. Drake (Buy at a value of $399 994), Susan C. Schnabel (Buy at a value of $300 930), Zachary William Stassen (Buy at a value of $318 250)
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Strong Buy | Strong Buy | Strong Buy |
ViewRay Inc is a radiation therapy and imaging technology company. It designs, manufactures and markets radiation therapy systems that provide real-time imaging during radiation treatment. Its product portfolio encompasses The MRIdian linac system, The MRIdian system, Monte Carlo treatment planning system, etc. The company holds license for its combination of MRI and radiation therapy technologies.
CEO: Scott W. Drake
Telephone: +1 440 703-3210
Address: 2 Thermo Fisher Way, Oakwood Village 44146, OH, US
Number of employees: 309
Thu, 05 Jan 2023 13:50 GMT Analysts Offer Insights on Healthcare Companies: Viewray (VRAY) and IN8bio (INAB)
- TipRanks. All rights reserved.Wed, 07 Sep 2022 11:55 GMT Viewray (VRAY) Receives a Buy from BTIG
- TipRanks. All rights reserved.Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer. The Cryptocurrency Market real-time data provided by Cryptocompare.com
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.